Leeward Investments LLC MA Sells 1,890 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Leeward Investments LLC MA decreased its position in Option Care Health, Inc. (NASDAQ:OPCH) by 0.4% during the 3rd quarter, Holdings Channel.com reports. The firm owned 432,912 shares of the company’s stock after selling 1,890 shares during the period. Leeward Investments LLC MA’s holdings in Option Care Health were worth $13,550,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. Massachusetts Financial Services Co. MA acquired a new position in Option Care Health in the 2nd quarter valued at $68,003,000. Magnetar Financial LLC grew its stake in shares of Option Care Health by 124.8% in the second quarter. Magnetar Financial LLC now owns 2,481,935 shares of the company’s stock valued at $68,750,000 after acquiring an additional 1,377,929 shares in the last quarter. Duquesne Family Office LLC increased its position in Option Care Health by 172.8% during the second quarter. Duquesne Family Office LLC now owns 1,871,818 shares of the company’s stock worth $51,849,000 after acquiring an additional 1,185,613 shares during the period. Hood River Capital Management LLC raised its stake in Option Care Health by 77.2% in the 2nd quarter. Hood River Capital Management LLC now owns 1,729,029 shares of the company’s stock worth $47,894,000 after purchasing an additional 753,208 shares in the last quarter. Finally, Westfield Capital Management Co. LP boosted its holdings in Option Care Health by 15.4% in the 1st quarter. Westfield Capital Management Co. LP now owns 5,171,385 shares of the company’s stock valued at $173,448,000 after purchasing an additional 688,653 shares during the period. 98.05% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the stock. Bank of America downgraded shares of Option Care Health from a “buy” rating to a “neutral” rating and dropped their price target for the company from $43.00 to $29.00 in a research report on Wednesday, October 30th. The Goldman Sachs Group lowered Option Care Health from a “buy” rating to a “neutral” rating and reduced their target price for the stock from $38.00 to $27.00 in a report on Monday. Barrington Research dropped their price target on Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research note on Thursday, October 31st. JMP Securities increased their price objective on shares of Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a research note on Monday, September 30th. Finally, Jefferies Financial Group cut shares of Option Care Health from a “buy” rating to a “hold” rating and dropped their target price for the company from $38.00 to $26.00 in a research report on Thursday, October 31st. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $30.83.

Insider Activity at Option Care Health

In related news, Director Elizabeth Quadros Betten sold 47,531 shares of the stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total value of $1,477,738.79. Following the completion of the transaction, the director now owns 21,339 shares of the company’s stock, valued at $663,429.51. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other Option Care Health news, Director Elizabeth Quadros Betten sold 47,531 shares of the stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total value of $1,477,738.79. Following the completion of the transaction, the director now directly owns 21,339 shares in the company, valued at approximately $663,429.51. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Michael H. Shapiro sold 23,217 shares of Option Care Health stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the sale, the chief financial officer now directly owns 247,317 shares in the company, valued at $7,654,461.15. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.64% of the stock is currently owned by insiders.

Option Care Health Stock Performance

Option Care Health stock opened at $23.50 on Thursday. The stock has a market cap of $4.00 billion, a PE ratio of 19.75, a P/E/G ratio of 2.33 and a beta of 1.32. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a 12-month low of $22.25 and a 12-month high of $34.63. The business’s 50-day moving average price is $30.14 and its two-hundred day moving average price is $29.79.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.